Nektar Therapeutics
NKTR
NKTR
145 hedge funds and large institutions have $79.3M invested in Nektar Therapeutics in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 49 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
-48
Holders Change %
-24.87%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
27
Reduced
49
Closed
72
Calls
$329K
Puts
$54K
Net Calls
+$275K
Net Calls Change
-$182K
Top Buyers
1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$10.3M |
2 |
MAM
Monaco Asset Management
Monaco
|
$5.33M |
3 |
SCM
Sio Capital Management
New York
|
$4.02M |
4 |
Citadel Advisors
Miami,
Florida
|
$5.58M |
5 |
D.E. Shaw & Co
New York
|
$5.26M |